← Back to Search

Telehealth Weight Loss Program for Breast Cancer Survivors (TWL Trial)

N/A
Recruiting
Led By Julia C Tchou, MD, PhD
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

TWL Trial Summary

This trial is looking at how well a weight-loss intervention works for breast cancer survivors, using video conferencing for visits.

Eligible Conditions
  • Breast Cancer
  • Obesity
  • Cancer Survivors

TWL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine feasibility and Acceptability Using the City of Hope Quality of Life Instrument - Breast Cancer Patient to Assess Changes in Quality of Life
Determine feasibility and Acceptability Using the International Physical Activity Questionnaire to Assess Changes in Physical Activity
Determine feasibility and Acceptability Using the Patient Health Questionnaire to Assess Changes in Measures of Depression
+2 more
Secondary outcome measures
To measure changes from pre- to post-weight-loss intervention for 1) body mass.
To measure changes from pre- to post-weight-loss intervention for 2) Qualitative Changes in Mammographic Breast Density
To measure changes from pre- to post-weight-loss intervention for 2) Quantitative Changes in Mammographic Breast Density

TWL Trial Design

1Treatment groups
Experimental Treatment
Group I: Single-Arms Longitudinal GroupExperimental Treatment3 Interventions
Behavioral weight-loss program via telehealth (video conferencing). Participants will receive weekly group sessions of lifestyle counseling for the first 20-weeks, followed by every other week sessions in weeks 22 and 24, for a total of 6-months of intervention.

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
105,950 Total Patients Enrolled
41 Trials studying Breast Cancer
35,313 Patients Enrolled for Breast Cancer
Abramson Cancer Center at Penn MedicineLead Sponsor
393 Previous Clinical Trials
147,534 Total Patients Enrolled
44 Trials studying Breast Cancer
60,829 Patients Enrolled for Breast Cancer
Julia C Tchou, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

Behavioral Weight-loss Program Via Telehealth Clinical Trial Eligibility Overview. Trial Name: NCT04855552 — N/A
Breast Cancer Research Study Groups: Single-Arms Longitudinal Group
Breast Cancer Clinical Trial 2023: Behavioral Weight-loss Program Via Telehealth Highlights & Side Effects. Trial Name: NCT04855552 — N/A
Behavioral Weight-loss Program Via Telehealth 2023 Treatment Timeline for Medical Study. Trial Name: NCT04855552 — N/A
~5 spots leftby Jun 2025